XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities    
Net loss $ (32,058) $ (31,410)
Adjustments to reconcile net loss to net cash, cash equivalents, and restricted cash used in operating activities    
Depreciation and amortization 1,569 1,806
Amortization of lease right-of-use assets 1,394 728
Loss on extinguishment of liabilities, net   2,952
Share-based compensation expense 3,338 2,714
Change in fair value of warrant liability (61)  
Provision for doubtful accounts 367 (39)
Accrued interest, amortization of debt issuance costs and other 2,695 2,174
Inventory excess and obsolescence 115 535
Impairment loss on intangible assets 20 81
Changes in operating assets and liabilities:    
Accounts receivable 580 (1,757)
Other current assets 1,349 690
Other long-term assets   933
Accounts payable and other accrued liabilities 1,236 (1,195)
Deferred revenue 49 (392)
Tenant improvement allowances received 12,978  
Current and long-term operating lease liabilities (320) (513)
Net cash and cash equivalents and restricted cash used in operating activities (6,749) (22,693)
Cash flows from investing activities    
Purchase of property and equipment (14,093) (591)
Patent costs and intangible asset acquisition, net (85) (141)
Net cash and cash equivalents and restricted cash used in investing activities (14,178) (732)
Cash flows from financing activities    
Proceeds from the issuance of common stock   16,135
Proceeds from issuance of common stock under employee stock purchase plan 420 202
Proceeds from exercise of stock options 87 92
Payment of contingent consideration (4,262) (6,625)
Proceeds from term loan and notes payable   15,102
Repayment of term loan and notes payable (24) (3,025)
Payment of debt issuance costs (832) (2,115)
Deferred offering costs   (129)
Equity financing costs (61) (323)
Other (79) (15)
Net cash and cash equivalents and restricted cash (used in) provided by financing activities (4,751) 19,299
Net decrease in cash and cash equivalents and restricted cash (25,678) (4,126)
Cash, cash equivalents, and restricted cash ‑ beginning of period 43,174 32,798
Cash, cash equivalents, and restricted cash ‑ end of period 17,496 28,672
Supplemental cash flow information:    
Common stock issued for deferred offering costs   600
Deferred offering costs amortized against Additional paid-in capital   18
Original issue discount associated with Promissory Note One   1,025
Deferred issuance costs included in Accounts payable and other accrued liabilities   118
Issuance of Perceptive Warrants 674  
Equity financing costs included in Accounts payable and other accrued liabilities   47
Operating lease right-of-use assets obtained in exchange for lease liabilities at adoption of ASC 842   1,269
Operating lease right-of-use assets obtained in exchange for lease liabilities 858 3,403
Finance lease right-of-use assets obtained in exchange for lease liabilities 773 123
Cash paid for interest 2,119 $ 344
Purchases of property & equipment included in Accrued liabilities $ 27